Effective Management of Nasal Vestibule Squamous Cell Carcinoma with Cemiplimab: A Case Report

Nasal vestibule squamous cell carcinoma (SCC) is a rare malignancy with limited treatment options. This case report presents an 83-year-old female with SCC of the nasal vestibule who was ineligible for surgery or radiotherapy due to various factors. The patient was successfully treated with cemiplim...

Descripción completa

Detalles Bibliográficos
Autores principales: Costabile, Ferdinando, Donnarumma, Marianna, Piscosquito, Arianna, Ingenito, Concetta, Iuliucci, Michela Rosaria, Buonerba, Carlo, Di Lorenzo, Giuseppe, Di Trolio, Rossella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601738/
https://www.ncbi.nlm.nih.gov/pubmed/37900804
http://dx.doi.org/10.1159/000531843
Descripción
Sumario:Nasal vestibule squamous cell carcinoma (SCC) is a rare malignancy with limited treatment options. This case report presents an 83-year-old female with SCC of the nasal vestibule who was ineligible for surgery or radiotherapy due to various factors. The patient was successfully treated with cemiplimab, a systemic anti-PD-1 antibody, resulting in a remarkable tumor reduction without any observed side effects. This is the first reported case of nasal vestibule SCC treated with cemiplimab, highlighting its potential as a promising therapeutic option.

Ejemplares similares